Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma

Brand V, Greve B, Bölling T, Eich HT, Willich N, Harrach S, Hintelmann H, Lenz G, Mesters RM, Kessler T, Schliemann C, Berdel WE, Schwöppe C

Research article (journal) | Peer reviewed

Abstract

Irradiation renders tumor and tumor vascular cells procoagulant by PS upregulation on their outer surface and radiotherapy can significantly improve the therapeutic antitumor efficacy of tTF-NGR in the xenograft model used. This synergistic effect will influence design of future clinical combination studies.

Details about the publication

JournalPloS one (PLoS One)
Volume15(2)
StatusPublished
Release year2020 (21/02/2020)
Language in which the publication is writtenEnglish
DOI10.1371/journal.pone.0229271

Authors from the University of Münster

Berdel, Wolfgang Eduard
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Bölling, Tobias
Clinic for Radiotherapy
Eich, Hans Theodor
Clinic for Radiotherapy
Greve, Burkhard
Clinic for Radiotherapy
Harrach, Saliha
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Keßler, Torsten
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Lenz, Georg
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Mesters, Rolf Michael
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Schliemann, Christoph
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Schwöppe, Christian
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Willich, Normann
Clinic for Radiotherapy
Zerbst, Caroline
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)